Search for: "Weeks v. Merck " Results 121 - 140 of 335
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jan 2010, 3:32 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Wellbutrin (Bupropion) – US: An employee benefit plan files motion to certify class action against Biovail and GlaxoSmithKline alleging companies conspired to delay generic Wellbutrin by filing baseless patent suits (GenericsWeb) Emend (Fosaprepitant dimeglumine) – US: FDA issues exclusivity decision… [read post]
20 Jan 2020, 9:54 am
Never Too Late 248 [Week ending 12 Jan] IPKat Book of the Year Awards 2019 winners announced! [read post]
6 Jan 2017, 2:01 am
Been away and want to catch up on last week's IP news? [read post]
16 Feb 2018, 12:45 am
".Never too Late 178 [week ending 14 January] A Merck-y appeal is remitted to the High Court | Into fashion law? [read post]
28 Jun 2010, 3:08 am
 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
27 Jun 2010, 6:00 pm by Duncan
 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
27 May 2010, 3:20 am
(Patent Docs) Zetia (Ezetimibe) - US: Merck and Glenmark settle Zetia patent suit (Patent Docs)   [read post]
6 Apr 2011, 12:18 am by Marie Louise
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while… [read post]
1 Dec 2017, 6:20 am
[Week ending 12 November]Exciting times in SEPs world! [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
25 Mar 2016, 2:11 pm
 Such a declaration takes support from Arrow Generics Ltd v Merck & Co Inc .FKB's declaration intends to establish that its products were anticipated or obvious at the priority dates of the two patents. [read post]
10 Sep 2019, 3:31 pm
Licensed Attorney for Foreign Trademark Applicants and Registrants" now in effectNever Too Late 230  [Week ending 11th August] The IPKat team: arrivals, farewells, and news | Nokia v. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Highlights this week included: Supreme Court shuts another door on patent settlement agreement antitrust challenge – denies certiorari in Cipro case: Louisiana Wholesale Drug Co. v. [read post]
21 Dec 2017, 7:09 am
Mermeren v Fox ISir Robin Jacob calls for System 2 thinking for patent law I Florence court prohibits unauthorized commercial use of David's image I Thursday Thingies [Week ending 3 December] Clash of the beer pongs - Breakthrough Funding Ltd v Nearby Media Ltd I WTO establishes panel to examine Qatar’s complaint against UAE I What's next for trade marks in the UK and EU? [read post]
13 Jan 2017, 9:24 am
  A declaration in these terms is described as an Arrow declaration, due to the form of relief sought in Arrow Generics Limited v Merck & Co. [read post]
11 Jan 2011, 11:07 pm by Kelly
Highlights this week included: US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post Grant Blog) (PharmaPatents) (IPBiz) US: Reverse payment settlements return to the Supreme Court: Louisiana Wholesale Drug Co et al v Bayer et al (Patently-O) (FDA Law Blog) Kaletra (Ritonavir, Lopinavir) – India: Abbott’s patent on AIDS medicine denied (IP Watch) (Spicy IP) (SiNApSE) Please join the discussion by adding your comments on… [read post]